Results 161 to 170 of about 134,412 (308)

Single‐center experience of the Crohn's disease exclusion diet in the United States: A retrospective study

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background The Crohn's Disease Exclusion Diet (CDED) offers a dietary means of inducing and maintaining remission for patients with Crohn's disease (CD). Descriptions of efficacy have emerged primarily from Israel, Europe, and Canada. Here, we offer real‐world experience, from a tertiary care center in the United States. Methods We conducted a
Mayah Greenfield   +5 more
wiley   +1 more source

Gastrointestinal: Ileum Obstruction by Gallstone

open access: yes, 1900
Obstruction of ileum by gallstones. Comment: Gallstone not now present (incised area contained stone); dilatation of proximal portion of bowel (from incised area to lower end of specimen) secondary to ...
MUSC Department of Pathology and Laboratory Medicine
core  

Investigation of capsaicin-ınduced morphometric changes, ıgf-ı and ıgf-ır expressions in rat ıleum abstract

open access: yes
Bu çalışma kapsaisin uygulaması sonrası ileumdaki histomorfolojik değişiklik ve endokrin, parakrin, otokrin etkiler yoluyla hücresel büyümeyi, farklılaşmayı ve apoptozu düzenlemede rol alan IGFI ve onun reseptörü olan IGFI-R’nün ifadesi araştırılmıştır ...
Asmaz, Ender Deniz
core   +1 more source

Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's disease

open access: yesNeuroprotection, EarlyView.
In Parkinson's disease (PD) and Alzheimer's disease (AD), various shared pathological mechanisms exist. UDCA has been shown to exert neuroprotective effects in preclinical and clinical studies. Such effects include the mitigation of neuroinflammation as well as rescue effects on mitochondrial dysfunction, oxidative stress, impaired autophagy, and ...
Ashley En Yi Chong   +3 more
wiley   +1 more source

Analysis of C4 Concentrations to Predict Impact of Patient‐Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 596-605, March 2025.
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño   +4 more
wiley   +1 more source

Intestinal Web in Jejunum and Ileum among Children: A series of 11 cases

open access: yesPakistan Journal of Medical Research
Objective: Web in the small intestine of children is not a commonly encountered entity. Due to partial obstruction, patients may present with varied symptoms and at different ages.
Naveed Haider   +9 more
doaj   +2 more sources

Phytochemicals in MASLD: A Focused Review of Gut Microbiome‐Linked Mechanisms

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as a major global health burden, yet effective pharmacological options remain limited. Recent advances highlight the gut microbiome as a key modulator of liver metabolism, inflammation, and fibrosis, making it a promising therapeutic target.
Jeong In Seo, Su Min Kim, Hye Hyun Yoo
wiley   +1 more source

Farnesoid X receptor prevents hyperuricemia via activating ATP‐binding cassette subfamily G member 2

open access: yesRheumatology &Autoimmunity, EarlyView.
Farnesoid X receptor (FXR) activation reduces serum uric acid levels by upregulating the intestinal urate transporter ATP‐binding cassette subfamily G member 2 (ABCG2). These findings uncover a novel metabolic pathway for urate excretion and suggest that FXR agonists (e.g., obeticholic acid), represent a promising therapeutic strategy for the treatment
Rui Li   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy